Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Research

THE EFFECT OF RECOMBINANT HUMAN FIBROBLAST GROWTH FACTOR-18 ON ARTICULAR CARTILAGE FOLLOWING SINGLE IMPACT LOAD

British Orthopaedic Research Society (BORS)



Abstract

Background

Mechanical trauma to articular cartilage is a known risk factor for Osteoarthritis (OA). The application of single impact load (SIL) to equine articular cartilage is described as a model of early OA changes and shown to induce a damage/repair response. Recombinant Human Fibroblast Growth Factor-18 (rhFGF-18) has been previously shown to have anabolic effects on chondrocytes in vitro. The aim of this in vitro study was to ascertain the effect of rhFGF-18 on the repair response of mechanically damaged articular cartilage.

Methods

Articular cartilage discs were harvested from healthy mature horses (n=4) and subjected to single impact load using a drop tower device. The impacted explants, together with unimpacted controls were cultured in modified DMEM +/− 200ng/ml rhFGF-18 for up to 30 days. Glycosaminoglycan (GAG) release into the media was measured using the dimethylmethylene blue (DMMB) assay, aggrecan neopepitope CS846 and Collagen Propeptide II (CPII) were measured by ELISA. Histological analysis, immunohistochemistry and TUNEL staining were used to assess proteoglycan content, type II and type VI collagen localisation, cell morphology, repair cell number and cell death.

Results

Impacted explants treated with rhFGF-18 showed significantly more GAG release and CS846 release into the media compared to other experimental groups (p<0.05), but no significant increase in CPII levels. Loaded sections treated with rhFGF-18 had increased type II and VI collagen immunohistochemistry scores, more repair cells on the tissue surface and significantly less cell death (p<0.001) compared to other experimental groups at day 30 in culture.

Conclusion

In an in vitro damage/repair model, rhFGF-18 increases the proteoglycan synthesis, collagen type II and VI protein within sections and the repair cell number and prevents apoptosis at Day 30. This suggests that rhFGF18 may be a good candidate for enhancement of cartilage repair following mechanical damage.